Thomas A. Treibel et al. JACC 2018;71:

Slides:

Advertisements

Similar presentations

STS 2015 John V. Conte, MD Professor of Surgery Johns Hopkins University School of Medicine On Behalf of the CoreValve US Investigators Transcatheter Aortic.

Advertisements

Trileaflet Aortic Valve. Management strategy for patients with chronic severe aortic regurgitation. Preoperative coronary angiography should be performed.

PARTNER Objective To compare surgical aortic valve replacement (AVR) with transcatheter aortic valve replacement (TAVR) in high-risk patients with severe.

© 2012 EuroIntervention. All rights reserved. EuroIntervention 2009;5: A comparison of patient characteristics and 30-day mortality outcomes after.

Professor Martin T Rothman Director Cardiac Research & Development Barts & The London NHS Trust London, England Professor Martin T Rothman Director Cardiac.

CONCESSIONS AVAILED DURING THANKSGIVING WEEK 43 FREE / CONCESSIONAL ANGIOGRAPHIES 280 FREE CARDIAC CONSULTATIONS 100 ECG at 50% CONCESSION 50 2 D ECHO.

Tri-leaflet Aortic Valve. Aortic Stenosis Nishimura, RA et al AHA/ACC Valvular Heart Disease Guideline.

Causes of Heart Valve Dysfunction Congenital defects (bicuspid aortic valve) Infections (rheumatic fever and bacterial endocarditis Coronary artery disease.

Date of download: 6/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: The Emerging Role of Exercise Testing and Stress.

EXPANDING INDICATIONS OF TRANSCATHETER HEART VALVE INTERVENTIONS. JACC CARDIOVASCULAR INTERVENTION. DR.RAJAT GANDHI.

Affordable Heart Surgery Available in India. Different Heart Surgeries  Angiography  Angioplasty with one medicated stent  Coronary Angioplasty (Including.

Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Early Anticoagulation of Bioprosthetic Aortic Valves.

© free-ppt-templates.com 2017 AHA/ACC Focused Update of Valvular Heart Disease Guideline of 2014 DR. OMAR SHAHID TR CARDIOLOGY SZH.

Longest Follow-up After Implantation of a Self-Expanding Repositionable Transcatheter Aortic Valve: Final Follow-up of the Evolut R CE Study Stephen Brecker,

British Society of Cardiovascular Magnetic Resonance

Nat. Rev. Cardiol. doi: /nrcardio

Copyright © 2012 American Medical Association. All rights reserved.

The American Journal of Medicine

Clinical presentation of myocardial infarction contributes to lower use of coronary angiography in patients with chronic kidney disease D.M. Charytan,

Velocity-encoded imaging (phase contrast mapping) to assess trans- and paravalvular regurgitation after transcatheter aortic valve replacement (TAVR).

Transcatheter or Surgical Aortic Valve Replacement in Intermediate Risk Patients with Aortic Stenosis Description: The goal of the trial was to assess.

Treatment of acute renal failure

CoreValve Continued Access Study Shows Continued Improvement in 1-Year Outcomes With Self-Expanding Transcatheter Aortic Valve Replacement Steven J. Yakubov,

Six-month–adjusted survival after aortic valve replacement (AVR) for severe aortic stenosis (AS) stratified by procedure and preoperative ejection fraction.

Algorithms proposed by the Heart Valve Clinic International Database (HAVEC) group for disease staging and management in patients with aortic valve stenosis.

by Mario Gössl, Garvan C. Kane, William Mauermann, and David R. Holmes

Richard S. D’Agostino, MD, Jeffrey P

Glenn N. Levine et al. JACC 2016;68:

Figure 10 Assessment of myocardial fibrosis

Clinical presentation of myocardial infarction contributes to lower use of coronary angiography in patients with chronic kidney disease D.M. Charytan,

Update in Cardiac and Thoracic Surgery

Lars A. Dejgaard et al. JACC 2018;72:

Mean eGFR among survivors after CABG surgery vs all-cause deaths

The American Association for Thoracic Surgery 2016 Ethics Forum: Cost-effectiveness and the ethics of left ventricular assist device therapy John W.C.

Lars A. Dejgaard et al. JACC 2018;72:

Valve repair improves the outcome of surgery for chronic severe aortic regurgitation: A propensity score analysis Christophe de Meester, MS, Agnès Pasquet,

Management of Patients With Aortic Valve Stenosis

Transcatheter or Surgical Aortic Valve Replacement in Patients With Prior Coronary Artery Bypass Grafting John V. Conte, MD, Thomas G. Gleason, MD, Jon.

Nat. Rev. Cardiol. doi: /nrcardio

Johannes Steiner et al. JACC 2017;70:

Johannes Steiner et al. JACC 2017;70:

Aspects to be considered by the Heart Team for the decision between TAVR and SAVR in patients at increased surgical risk. Aspects to be considered by the.

Long-Term Consequences of Postoperative Heart Failure After Surgery for Aortic Stenosis Compared With Coronary Surgery Farkas B. Vánky, MD, PhD, Erik.

Aortic valve replacement in patients with mild or moderate aortic stenosis and coronary bypass surgery Jeremy J. Pereira, MB, Krzysztof Balaban, MD,

Figure 2 A patient with aortic stenosis and mitral regurgitation

G. James Avery, MD, S. Jill Ley, RN, J

Nat. Rev. Cardiol. doi: /nrcardio

Management of High-Risk Patients With Aortic Stenosis and Coronary Artery Disease Daniel Wendt, MD, Philipp Kahlert, MD, Tim Lenze, Markus Neuhäuser,

Change in symptoms in operated and unoperated patients 1 year following evaluation of surgical AVR. Pie charts display change from baseline to follow-up.

Suggested pathway for assessment of aortic valve replacement dysfunction. Suggested pathway for assessment of aortic valve replacement dysfunction. Transthoracic.

Richard S. D’Agostino, MD, Jeffrey P

Miralem Pasic et al. JCIN 2015;8:1-9

Kaplan-Meier curves: revascularisation rate (PCI or CABG) was significantly higher (p

Impact of Intraoperative Transesophageal Echocardiography on Surgical Decisions in 12,566 Patients Undergoing Cardiac Surgery Holger K. Eltzschig, MD,

Impact of Transcatheter Technology on Surgical Aortic Valve Replacement Volume, Outcomes, and Cost Robert B. Hawkins, MD, Emily A. Downs, MD, Lily E.

Treatment of acute renal failure

Nicolaj C. Hansson et al. JACC 2016;68:

Michele Gallo, MD, Gino Gerosa, MD

Outcomes of Transcatheter and Surgical Aortic Valve Replacement in Patients on Maintenance Dialysis Fahad Alqahtani, MD, Sami Aljohani, MD, Khaled Boobes,

Influence of experience and the surgical learning curve on long-term patient outcomes in cardiac surgery Bryan M. Burt, MD, Andrew W. ElBardissi, MD,

Cox regression of proportion mortality in the first 8 years for patients with three-vessel disease with a significant difference between the treatment.

Glenn N. Levine et al. JACC 2011;58:e44-e122

N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels for patients undergoing surgical aortic valve replacement (SAVR) (A), patients undergoing.

Stroke in cardiac surgical patients: determinants and outcome

Matias B. Yudi et al. JACC 2018;71:

Sung-Han Yoon et al. JACC 2017;69:

Ander Regueiro et al. JACC 2017;69:

Trend of complications for patients undergoing bioprosthetic mitral valve replacement (MVR) for mitral regurgitation between 2003 and Trend of complications.

National trends in utilization and in-hospital outcomes of mechanical versus bioprosthetic aortic valve replacements Abby J. Isaacs, MS, Jeffrey Shuhaiber,

Miralem Pasic et al. JCIN 2015;8:1-9

Presentation transcript:

Thomas A. Treibel et al. JACC 2018;71:860-871 Study Flow Chart A total of 181 patients with severe, symptomatic aortic stenosis were recruited (48% of all surgical aortic valve replacements [AVR] at our institution [University College London Hospital NHS Trust, London, United Kingdom]). Before AVR, 10 patients were excluded (claustrophobia [n = 4], cardiac amyloid [n = 2], severe mitral regurgitation [n = 2], pseudosevere aortic stenosis [n = 1], Fabry disease [n = 1]), and 3 patients did not undergo AVR and were treated medically. Following AVR (164 surgical, 4 transcatheter), 4 further patients were excluded because of cardiac amyloid. By 1 year, there were 11 deaths and 16 patients with pacemakers; 21 patients declined follow-up. A total of 116 patients underwent 1-year follow-up assessment. CABG = coronary artery bypass grafting; CMR = cardiac magnetic resonance; eGFR = estimated glomerular filtration rate; mAVR = mechanical aortic valve replacement; pre OP = pre-operative; TAVR = transcatheter aortic valve replacement; tAVR = tissue bioprosthetic aortic valve replacement. Thomas A. Treibel et al. JACC 2018;71:860-871 2018 The Authors